Click to copy
Click to copy

Galmed Pharmaceuticals: 2Q Earnings Snapshot

August 5, 2019

TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Monday reported a loss of $4.2 million in its second quarter.

The Tel Aviv, Israel-based company said it had a loss of 20 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

Galmed Pharmaceuticals shares have fallen 17% since the beginning of the year. The stock has fallen 58% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLMD at https://www.zacks.com/ap/GLMD

All contents © copyright 2019 The Associated Press. All rights reserved.